Clinical Trial Update: Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study update evaluating the reproducibility of the BodyFIX immobilization device in Hodgkin lymphoma and non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hodgkin's Disease, Lymphoma, Non-Hodgkin | Phase 1, Phase 2 | Status: COMPLETED